REVIEW JNJ-7706621 is a dual inhibitor of cyclin-dependent kinases (CDK) and Aurora kinases. It demonstrates highest potency on CDK1/2 with IC50 values of 9 nM and 4 nM respectively. It shows more than 6-fold selectivity for CDK1/2 over CDK3/4/6.
All in-stock products are shipped from San Francisco Bay Area, California, USA.
⚠️
These products are explicitly not intended to be used in foods and/or cosmetics and/or drugs (human and veterinary) and/or consumer products and/or biocides and/or pesticides of any kind unless explicitly stated otherwise.
Products are not sold to individuals. We do not ship to residential addresses. Consumer orders will be cancelled without notice.
New customers undergo an internal onboarding process. As part of this process, new customers may be asked for more information. Additional restrictions may apply.